Bersiporocin is an orally effective prolyl-tRNA synthetase (PRS) inhibitor. Bersiporocin exerts antifibrotic effects by inhibiting collagen synthesis. Bersiporocin can be used in the research of pulmonary fibrosis[1].
Molecular Weight:
328.24
Purity:
98.99
CAS Number:
[2241808-52-4]
Formula:
C15H19Cl2N3O
Target:
Aminoacyl-tRNA Synthetase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
